Literature DB >> 17275844

VEGF is important for early liver regeneration after partial hepatectomy.

Maximilian Bockhorn1, Michal Goralski, Dennis Prokofiev, Philipp Dammann, Petra Grünewald, Martin Trippler, Alireza Biglarnia, Markus Kamler, Eva M Niehues, Andreja Frilling, Christoph E Broelsch, Jörg F Schlaak.   

Abstract

BACKGROUND: The aim of the study was to determine the role of Vascular Endothelial Growth Factor (VEGF) on the microvasculature and on angiogenetic gene expression after partial hepatectomy (PH) in the rat model.
METHODS: To determine the effect of exogenous and endogenous VEGF after PH, rats were subjected to 70% PH and treated either with VEGF, anti-VEGF or NaCl. Postoperatively (3-168 h), vessel density (VD), vessel diameter (VDi), and intersinusoidal space, liver body weight ratio (LBR), hepatic proliferation and biochemical markers were assessed. To further elucidate the underlying molecular mechanisms hepatic gene expression was determined by customized cDNA arrays and quantitative RT-PCR.
RESULTS: In the VEGF group, VD, VDi, and LBR were significantly increased compared with anti-VEGF or controls. Blockage of endogenous VEGF led to a marked increase of biochemical markers. Anti-VEGF almost completely suppressed and VEGF markedly enhanced hepatic proliferation in the first 24 h after surgery. This was associated with a modulation of cell cycle control genes (PC4, Gadd45a, Tis21/BTG2), v-jun, and CD14 by VEGF.
CONCLUSIONS: VEGF plays an important role in liver regeneration and this may be due in part through its effects on neovascularization. Whether it may, when given therapeutically, represent a strategy to optimize liver regeneration in problematic patients needs to be clarified.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275844     DOI: 10.1016/j.jss.2006.07.027

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  34 in total

1.  Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro.

Authors:  Xiao-Lei Shi; Jin-Yang Gu; Yue Zhang; Bing Han; Jiang-Qiang Xiao; Xian-Wen Yuan; Ning Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration.

Authors:  Jan-Peter Sowa; Jan Best; Tamas Benko; Maximillian Bockhorn; Yanli Gu; Eva-Maria Niehues; Agnieska Bucchi; Eva-Maria Benedetto-Castro; Guido Gerken; Ursula Rauen; Jorg-Friedrich Schlaak
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

3.  Hypoxic Conditioned Medium From Human Adipose-Derived Stem Cells Promotes Mouse Liver Regeneration Through JAK/STAT3 Signaling.

Authors:  Sang Chul Lee; Hye Jin Jeong; Sang Kuon Lee; Say-June Kim
Journal:  Stem Cells Transl Med       Date:  2016-04-21       Impact factor: 6.940

Review 4.  Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases.

Authors:  De-Bang Li; Feng Ye; Xiu-Rong Wu; Lu-Peng Wu; Jing-Xi Chen; Bin Li; Yan-Ming Zhou
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

5.  Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells.

Authors:  Lin Wang; Xiangdong Wang; Lei Wang; Jenny D Chiu; Gijs van de Ven; William A Gaarde; Laurie D Deleve
Journal:  Gastroenterology       Date:  2012-08-15       Impact factor: 22.682

6.  Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid.

Authors:  Rui E Castro; Duarte M S Ferreira; Xiaoxiao Zhang; Pedro M Borralho; Aaron L Sarver; Yan Zeng; Clifford J Steer; Betsy T Kren; Cecília M P Rodrigues
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-05       Impact factor: 4.052

7.  Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration.

Authors:  U Shergill; A Das; D Langer; Rs Adluri; N Maulik; V H Shah
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05       Impact factor: 3.619

8.  Administration of anti-vascular endothelial growth factor antibody following hepatectomy does not inhibit remnant liver regeneration or growth of remnant metastases.

Authors:  Kazuhiko Kasuya; Minako Suzuki; Yuichi Nagakawa; Yoshiaki Suzuki; Satoru Kikuchi; Bunso Kyo; Takaaki Matsudo; Takao Itoi; Akihiko Tsuchida; Tatsuya Aoki
Journal:  Exp Ther Med       Date:  2011-12-06       Impact factor: 2.447

9.  Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases.

Authors:  Daria Zorzi; Yun Shin Chun; David C Madoff; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2008-07-18       Impact factor: 5.344

10.  Impact of hepatic vein deprivation on liver regeneration and function after major hepatectomy.

Authors:  Maximilian Bockhorn; Tamasz Benkö; Bettina Opitz; Sien-Yi Sheu; Georgios C Sotiropoulos; Jörg F Schlaak; Christoph E Broelsch; Hauke Lang
Journal:  Langenbecks Arch Surg       Date:  2007-09-12       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.